Sipra Labs Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U85195TG1994PLC016912 Incorporated 21 January 1994 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹10.01 Cr
▼ 19% YoY
Net profit · FY 2024
₹1.18 Lakh
Net margin 0.1%
EBITDA · FY 2024
₹1.71 Cr
EBITDA margin 17.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.01 Cr
Issued & subscribed
Satisfied charges
₹57.4 Cr
No open charges
Company age
32 yrs
Est. 1994
Employees · EPFO
74
Provident fund records

About Sipra Labs Limited

Data last updated:

Sipra Labs Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 21 January 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85195TG1994PLC016912. Its GSTIN is 36AACCS8315H1ZB (Telangana). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.01 Cr. It was formerly known as Sipra Labs Private Limited. It is led by directors including Satya Narayana Vemulapalli (Managing Director) and Srihari Vemulapalli (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.7 – 2 – 1813/5/A Sy.No.59/6 Industrial Estate Sanath Nagar, Hyderabad, Telangana, India – 500018.

As per the financials filed for FY 2024, the company reported a revenue of ₹10.01 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.18 Lakh (net margin 0.1%) and EBITDA of ₹1.71 Cr (EBITDA margin 17.1%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.

The company has about 74 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand: Sipra Labs. As per MCA filings, the company has satisfied charges of ₹57.4 Cr on record. Court records list 14 cases involving the company, including 5 filed by the company and 9 filed against it; 5 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sipralabs.com.

Company details

CIN U85195TG1994PLC016912
Registration Number 016912
Incorporation Date 21 January 1994
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Sipra Labs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U85195TG1994PLC016912, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U85195TG1994PLC016912Current
U85195AP1994PLC016912Previous
U85195AP1994PTC016912Previous

Contact details

Sipra Labs Limited's registered office is in Hyderabad, Telangana. Its website is sipralabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    H.No.7 – 2 – 1813/5/A Sy.No.59/6 Industrial Estate Sanath Nagar, Hyderabad, Telangana, India – 500018
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Sipra Labs Limited, buy the company report.

Comprehensive company report
Sipra Labs Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sipra Labs operates one associated brand: Sipra Labs. Each brand links to its own profile.

BrandDescriptionWebsite
Provides regulatory compliant research and development for pharma, biotech, and medical sectors.sipralabs.com

Business activity

The main business activity of Sipra Labs is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Sipra Labs Limited, buy the company report.

Financials of Sipra Labs Limited

FY 2025 filings available

Sipra Labs Limited reported revenue of ₹10.01 Cr (down 19% YoY) for FY 2024.

Revenue · FY 2024
₹10.01 Cr ▼ 19%
Net profit · FY 2024
₹1.18 Lakh margin 0.1%
EBITDA · FY 2024
₹1.71 Cr margin 17.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 14%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 29%
5 years · compounded
▼ 26%

Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 19% fall in the latest year. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.71 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.18 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin17.1%
Net Profit Margin0.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sipra Labs Limited, buy the company report.

Board of directors of Sipra Labs Limited

Sipra Labs has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Satya Narayana VemulapalliManaging Director21 Jan 199432 Years 9 MonthsCurrent
Srihari VemulapalliWhole-Time Director21 Jan 199432 Years 9 MonthsCurrent
Madhavi VemulapalliWhole-Time Director30 Sep 201610 Years 1 MonthsCurrent

Peer comparison

Sipra Labs Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Contract Pharmacal Corporation India Private Limited₹10.47 Cr (FY 2024)-3.0%Ahmedabad, Gujarat, India
Olene Life Sciences Private Limited₹10.14 Cr (FY 2025)169.0%Chennai, Tamil Nadu, India
Sipra Labs Limitedthis company₹10.01 Cr (FY 2024)₹1.18 Lakh0.1%-19.0%74Hyderabad, Telangana, India
Catawba Research (India) Private Limited₹9.86 Cr (FY 2025)-2.0%Mumbai, Maharashtra, India

To see the full peer comparison of Sipra Labs Limited, buy the company report.

Auditor

Sipra Labs Limited is audited by PATURI AND ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
PATURI AND ASSOCIATESFY 2022002611S

Shareholding

The shareholding of Sipra Labs Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sipra Labs Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹57.4 Cr
Breakdown by lending institutions
State Bank of India₹40.03 Cr
Bank of Bahrain and Kuwait B.Sc₹12.83 Cr
A.P. State Financial Corporation₹3.29 Cr
Canara Bank₹1.26 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Mar 201410484933State Bank of India₹15 CrSatisfied
10 Sep 201110306722Bank of Bahrain and Kuwait B.Sc₹12.83 CrSatisfied
18 Feb 200680058746State Bank of India₹25.03 CrSatisfied
19 Jan 200590121862A.P. State Financial Corporation₹2.82 CrSatisfied
26 Sep 200290121657Canara Bank₹1.26 CrSatisfied

To see the full charge records of Sipra Labs Limited, buy the company report.

Total charge records: 6 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sipra Labs Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Sipra Labs has 2 subsidiary companies. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.

2
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Vamet Electric Pvt LtdU31909TG1988PTC008765
Dietron Engineering Private LimitedU74210TG1982PTC003359

To see the full group structure of Sipra Labs Limited, buy the company report.

Employees & EPFO

Sipra Labs Limited has a workforce of 74 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.

Employee count
74
Active EPFO establishments
1
Employee growth
-21.28%

GST

Sipra Labs has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
36AACCS8315H1ZBTelanganaActive01 Jul 2017
37AACCS8315H1Z9Andhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Sipra Labs Limited, buy the company report.

Recent activity

Sipra Labs Limited has 6 board changes on record since 1994: 3 appointments and 3 cessations. The latest: Madhavi Vemulapalli ceased to be Director on 30 Sep 2019.

AGM
Sipra Labs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sipra Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Madhavi Vemulapalli ceased to be Director.
Ceased
Srihari Vemulapalli ceased to be Director.
Charges
A charge registered on 18 Feb 2006 via Charge ID 80058746 with State Bank Of India was fully satisfied on 07 Mar 2019.
Charges
A charge registered on 11 Mar 2014 via Charge ID 10484933 with State Bank Of India was fully satisfied on 04 Dec 2018.
Charges
A charge registered on 10 Sep 2011 via Charge ID 10306722 with Bank Of Bahrain And Kuwait B.Sc was fully satisfied on 04 Dec 2018.
Ceased
Vegunta Sita Rama Swamy ceased to be Director.
Appointed
Madhavi Vemulapalli was appointed as Whole-Time Director.
Charges
A charge with State Bank Of India of Rs. 15.00 Cr registered on 11 Mar 2014 with Charge ID 10484933 was modified on 22 Apr 2014.
Charges
A charge with State Bank Of India amounted to Rs. 15.00 Cr with Charge ID 10484933 was registered on 11 Mar 2014.
Charges
A charge registered on 26 Sep 2002 via Charge ID 90121657 with Canara Bank was fully satisfied on 04 Mar 2014.

11 earlier events are in the company report.

Frequently asked questions

Sipra Labs is an active public limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 21 January 1994 (32+ years old) and is registered under CIN U85195TG1994PLC016912.

Sipra Labs has 3 current directors:

The latest financial statements of Sipra Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Sipra Labs is 36AACCS8315H1ZB, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AACCS8315H1Z9 (Andhra Pradesh).

The CIN (Corporate Identification Number) of Sipra Labs is U85195TG1994PLC016912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sipra Labs has 14 court cases on record: 5 filed by the company and 9 filed against it. 5 are pending. Most are in the district courts.

Sipra Labs was incorporated on 21 January 1994, making it 32+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Sipra Labs by revenue are Contract Pharmacal Corporation India Private Limited, Olene Life Sciences Private Limited, Catawba Research (India) Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).

Madhavi Vemulapalli ceased to be Director on 30 Sep 2019. Srihari Vemulapalli ceased to be Director on 30 Sep 2019. Vegunta Sita Rama Swamy ceased to be Director on 15 Jun 2017. Sipra Labs has 6 board changes on record in total.

Sipra Labs can be reached through the website sipralabs.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Sipra Labs is at H.No.7 – 2 – 18135A Sy.No.596 Industrial Estate Sanath Nagar, Hyderabad, Telangana, India – 500018.